Musculoskeletal Disorders (1.00)
|
|
|
All musculoskeletal disorders except amputation of both extremities at or above the
wrists, hemipelvectomy, or hip disarticulation
|
04/02/2021
|
We so extensively revised the musculoskeletal listings in 2021 that while they are
not, in general, less restrictive than the prior listings, the issues are different
and include the use of different functional criteria to indicate listing-level severity.
If the prior claim was denied before 04/02/2021, prepare a new determination for all subsequent claims involving a musculoskeletal
impairment other than amputation of both upper extremities at or above the wrists,
hemipelvectomy, or hip disarticulation.
|
Special Senses and Speech (2.00)
|
|
|
All hearing impairments
|
08/02/10
|
We revised the listings for hearing impairments by removing the requirement for testing
with hearing aids and replacing listings 2.08 and 102.08 with new listings 2.10 and
102.10, respectively.
If the prior claim was denied before 08/02/10, prepare a new substantive determination for all subsequent claims involving hearing
loss.
|
Vision
|
04/29/13
|
If the prior claim was denied before 04/29/2013, prepare a new substantive determination for all subsequent claims involving vision.
|
Respiratory Disorders (3.00)
|
|
|
All respiratory disorders
|
10/07/16
|
We revised the listings for respiratory disorders. While the listings are not, in
general, less restrictive, we added new criteria.
If the prior claim was denied before 10/07/16, prepare a new substantive determination for any subsequent claim involving a respiratory
impairment.
|
Cardiovascular System(4.00)
|
|
|
All cardiovascular disorders
|
02/10/94
|
We revised the cardiovascular listings so extensively that, while they are not, in
general, less restrictive, the issues are different.
If the prior claim was denied before 02/10/94, prepare a new determination for all subsequent claims involving a cardiovascular
impairment.
|
Cardiovascular disorders: chronic heart failure; ischemic heart disease; peripheral
arterial disease
|
04/13/06
|
We revised the adult listings for chronic heart failure (4.02), ischemic heart disease
(4.04), and peripheral arterial disease (4.12). While the listings are not, in general,
less restrictive, we added new criteria or revised existing criteria to reflect technological
improvements.
If the prior claim was denied before 04/13/06, prepare a new substantive determination for all subsequent claims involving chronic
heart failure, ischemic heart disease, or peripheral arterial disease.
|
Digestive
Disorders
(5.00)
|
|
|
All digestive disorders
|
10/06/23
|
We so extensively revised the digestive disorders listings in 2023 that, while they
are not, in general, less restrictive than the prior listings, we added new criteria
or revised existing criteria to reflect technological improvements.
If the prior claim was denied before
10/06/23, prepare a new substantive determination for all subsequent claims involving any
digestive disorder.
|
Hematological Disorders (7.00)
|
|
|
All hematological disorders
|
05/18/15
|
We so extensively revised the hematological disorders listings in 2015 that, while
they are not, in general, less restrictive than the prior listings, the issues are
different and include the use of functional criteria to indicate listing-level severity.
If the prior claim was denied before 05/18/15, prepare a new determination for all subsequent claims involving a hematological
disorder impairment.
|
Skin Disorders (8.00)
|
|
|
All skin disorders except for Xeroderma Pigmentosum
|
10/06/23
|
We so extensively revised the skin disorders listings in 2023 that, while they are
not, in general, less restrictive than the prior listings, the issues are different
and include the use of different functional criteria to indicate listing-level severity.
If the prior claim was denied before
10/06/23, prepare a new substantive determination for all subsequent claims involving skin
disorders other than Xeroderma Pigmentosum.
|
Congenital Disorders That Affect Multiple Body Systems (10.00)
|
|
|
Non-mosaic Down syndrome in an individual age 18 or older
|
6/19/00
|
We added listing 10.06 for non-mosaic Down syndrome.
If the prior claim was denied before 06/19/00, prepare a substantive determination for all subsequent claims involving an individual
age 18 or older with non-mosaic Down syndrome.
|
Neurological Disorders (11.00)
|
|
|
Amyotrophic lateral sclerosis (ALS)
|
08/28/03
|
We revised the listing criteria for evaluating ALS under listing 11.10. We will find
disability with medical evidence showing that the claimant has ALS.
If the prior claim was denied before 08/28/03, prepare a new substantive determination for all subsequent claims involving ALS.
|
All neurological disorders except for ALS
|
09/29/16
|
We comprehensively revised the listings for evaluating neurological disorders. We
added new listings, removed 3 listings and included new functional criteria for most
listings.
If the prior claim was denied before 09/29/16, prepare a new substantive determination for all subsequent claims involving a neurological
disorder other than ALS.
|
Mental Disorders (12.00)
|
|
|
Mental Disorders
|
01/17/17
|
We extensively revised the mental disorders listings. While these listings are not,
in general, less restrictive, we extensively revised the areas of mental functioning
considered in the severity criteria.
If the prior claim was denied before 01/17/17, prepare a new substantive determination for all subsequent claims involving a mental
disorder.
|
Cancer (13.00)
|
|
|
Malignant neoplastic disease of the esophagus
|
01/06/86
|
We revised the listing for evaluating tumors located in the lower half of the esophagus
(13.16) to remove the requirement for metastatic disease.
If the prior claim was denied before 01/06/86, prepare substantive determination on subsequent claim involving a tumor located in
the lower half of esophagus if the prior claim was denied before 01/06/86.
|
Malignant neoplastic disease of the gallbladder
|
01/06/86
|
We revised the criteria for evaluation of carcinoma of the bile ducts to require less
extension of the tumors. This change is less restrictive.
If the prior claim was denied before 01/06/86, prepare a substantive determination on the subsequent claim involving carcinoma of
the bile ducts if the prior claim was denied before 01/06/86.
|
Malignant neoplastic disease of the penis
|
01/06/86
|
We added new listings to provide standards for tumors of the penis and vulva. (The
listing for tumors of the penis was 13.29 from 01/06/86 to 07/08/04. It was renumbered
to 13.26 beginning 07/09/04.)
If the prior claim was denied before 01/06/86, prepare a substantive determination on the subsequent claim involving tumors of the
penis.
|
-
•
Malignant neoplastic disease of: soft tissue of the head and neck; skin; breast; skeletal
system; lungs; small intestine; kidneys, adrenals, or ureters; female genital tract
-
•
Malignant neoplastic disease treated by bone marrow or stem cell transplantation
-
-
-
•
Primary site unknown after appropriate search
|
12/15/04
|
We revised the listings for these disorders (13.02C, 13.02E, 13.03A, 13.03B2, 13.06,
13.07, 13.10A, 13.11D, 13.14A, 13.17A, 13.21A, 13.23, 13.27, and 13.28). While these
listings are not, in general, less restrictive, we added criteria to recognize the
length and debilitating effects of treatment for some malignancies. We also:
-
•
added criteria for other types of tumors that have a similar prognosis as those already
in the listings;
-
•
revised the criteria for multiple myeloma to clarify that this listing includes all
listing-level manifestations of the disease; and
-
•
added criteria for tumors for which the site of origin cannot be determined.
If the prior claim was denied before 12/15/04, prepare a new substantive determination for all subsequent claims involving these
malignant neoplastic diseases.
|
Malignant neoplastic diseases of: skin; thyroid gland; breast; lungs; female genital
tract
|
11/5/09
|
We have revised the listings for these disorders (13.03B, 13.09C, 13.10B, 13.14C,
13.23C). While these listings may not, in general, be less restrictive, we added criteria
to recognize the length and debilitating effects of treatment for some malignancies.
We also added criteria for evaluating malignant neoplastic diseases of the skin, thyroid
gland, and breast.
If the prior claim was denied before 11/5/09, prepare a new substantive determination for all subsequent claims involving these
malignant neoplastic diseases.
|
Cancer
|
07/20/15
|
We have revised the listings and added some new listings for these disorders (13.02,
13.03, 13.05, 13.06, 13.10, 13.12, 13.13, 13.15, 13.16, 13.17, 13.18, 13.20, 13.22,
13.23, 13.24, 13.29). While these listings may not, in general, be less restrictive,
we added criteria to recognize the unfavorable prognoses and length and debilitating
effects of treatment for some malignancies.
If the prior claim was denied before07/20/15, prepare a new substantive determination for all subsequent claims involving these
malignant neoplastic diseases.
|
Immune System Disorders (14.00)
|
|
|
All immune system disorders except human immunodeficiency virus (HIV) infection, systemic
sclerosis, polymyositis and dermatomysitis, and inflamatory arthritis
|
06/16/08
|
We revised the listings for these disorders by either making them less restrictive
or making major changes that result in the listing criteria being significantly different.
For example, in some listings, we added functional criteria to indicate listing-level
severity.
If the prior claim was denied before 06/16/08, prepare a new substantive determination for all subsequent claims involving these
immune system disorders listings.
|
Human immunodeficiency virus (HIV) Infection
Systemic sclerosis, polymyositis and dermatomyositis, and inflammatory arthritis
|
01/17/17
04/02/2021
|
We revised the listing used to evaluate human immunodeficiency virus (HIV) infection.
While the new listing is not, in general, less restrictive, we have made a number
of significant changes. We have removed many criteria and added new criteria to reflect
medical advances and changes in expected outcomes for individuals with HIV infection.
If the prior
claim was denied before 01/17/17, prepare a substantive determination for all subsequent claims involving symptomatic
HIV infection.
We replaced the musculoskeletal functional criteria used to indicate listing-level
severity in these listings. While they are not, in general,less restrictive, the issues
are different.
If the prior claim was denied
before 04/02/21, prepare a new determination for all subsequent claims involving systemic sclerosis,
polymyositis and dermatomyositis, and inflammatory arthritis
|